Patent · US Active

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

US9603913B2 · kind B2 · utility

0Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2015
Grant dateMar 28, 2017
Priority date—
Expiry dateApr 1, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunogenic composition containing a glycan conjugate including a carrier protein, and a glycan including Globo H, an immunogenic fragment thereof, or stage-specific embryonic antigen-4 (SSEA-4), wherein the glycan is conjugated with the carrier protein through a linker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.